Theoretical study of the intermolecular recognition mechanism between Survivin and substrate based on conserved binding mode analysis

J Mol Graph Model. 2018 Aug:83:53-63. doi: 10.1016/j.jmgm.2018.05.001. Epub 2018 May 8.

Abstract

Survivin is the smallest member of IAP (inhibitor of apoptosis protein) family, which plays important roles in both mitosis and apoptosis. It has become an attractive drug target due to its overexpression in many human cancers. Survivin has been proven to bind to Smac/DIABLO protein that indirectly inhibits apoptosis. Meanwhile, it is the key subunit of chromosome passenger complex (CPC) which bind to the N-terminal tail of phosphorylated histone H3T3ph during mitosis. Up to now, Survivin directly targeting inhibitor has yet to merge since the difficulty of disrupting the protein-protein interactions (PPIs) between Survivin and its substrate proteins. Nevertheless, currently known binding partners of Survivin provide crucial information about conserved recognition mechanism, which can assist in the detection of some uncharted substrates and also the Survivin inhibitors. Herein, we adopted a method that using four substrates to analyze the common binding mode of Survivin. To accomplish this, conventional molecular dynamics (MD) simulations, molecular mechanics/generalized born surface area (MM-GBSA) binding free energy calculations and energy decomposition were carried out to assess the binding affinity and per-residue contributions. We found that there are two anchor sites of Survivin responsible for maintaining the binding conformation and one sub-pocket for intermolecular recognition. The results of this study synthetically describe the binding mechanism and provide valuable guidance for rational drug design of PPI inhibitor.

Keywords: Drug design; MD simulations; MM-GBSA; Protein-protein interaction; Recognition mechanism; Survivin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Binding Sites
  • Drug Design
  • Hydrogen Bonding
  • Ligands
  • Mitosis / drug effects
  • Molecular Docking Simulation*
  • Molecular Dynamics Simulation*
  • Peptides / chemistry
  • Protein Binding
  • Protein Conformation
  • Quantitative Structure-Activity Relationship
  • Survivin / antagonists & inhibitors
  • Survivin / chemistry*
  • Survivin / metabolism

Substances

  • Antineoplastic Agents
  • Ligands
  • Peptides
  • Survivin